https://www.selleckchem.com/products/sj6986.html
In both ACCORD and the VADT, the CV and ARV of FPG were associated with development of future microvascular outcomes even after adjusting for other risk factors, including measures of average glycemic control (ie, cumulative average of HbA1c). Meta-analyses of these 2 trials confirmed these findings and indicated FPG variation may be more harmful in those with less intensive glucose control. This post hoc analysis indicates that variability of FPG plays a role in, and/or is an independent and readily available marker of, development of m
Like
Comment
Share
